Clinical Trials Directory

Trials / Sponsors / Hyundai Pharmaceutical Co., LTD.

Hyundai Pharmaceutical Co., LTD.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedHDDO-1756 Bio Equivalence Study
Hyperlipidemias
Phase 12020-06-12
UnknownBPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease
Moderate-to-severe Alzheimer's Disease
Phase 32020-02-27
UnknownHDDO-1801 Intervention Trial
Respiratory Disease
Phase 12019-11-08
CompletedHDDO-1614 Bio Equivalence Study
Osteoporosis
Phase 12017-10-16
CompletedHDDO-1614 Intervention Trial
Osteoporosis
Phase 12017-04-12
CompletedCompare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchiti
Acute Bronchitis
Phase 32015-11-01
CompletedStudy to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers
Healthy Volunteers
Phase 12014-04-01
CompletedTo Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With C
Healthy Male
Phase 12013-10-01
CompletedCompare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200m
Healthy Male
Phase 12013-07-01
CompletedStudy To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volu
Healthy
Phase 12012-11-01
CompletedChange From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
Chronic Renal Failure
Phase 22010-01-01